Diltiazem reduces restenosis after percutaneous transluminal coronary angioplasty

Journal of Interventional Cardiology

Volumn 9, Issue 4, 1996, Pages 287-295

  Unverdorben, Martin ^a,e   Leucht, Markus ^b   Kunkel, Bernhard ^c   Gansser, Rolf ^a   Bachmann, Kurt ^d   Vallbracht, Christian ^a  

^a Ctr Cardiovasc Dis Rotenburg/F   (Germany)

^b Med Clin Comm Hosp Munchberg   (Germany)

^c Med Clin I Comm Hospital Bomberg   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e Center for Cardiovascular Diseases   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; HEPARIN; ISOSORBIDE DINITRATE; PLACEBO;

ADULT; AGED; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; BYPASS SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RESTENOSIS; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029774578     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1996.tb00631.x     Document Type: Article

References (57)

1. Gruentzig AR. Results from coronary angioplasty and implications for the future. Am Heart J 1982;103:779-782.
2. Holmes DR, Vlietstra RE, Smith HS, et al. Restenosis after coronary artery angioplasty: A report from the PTCA registry of The National Heart, Lung, and Blood Institute. Am J Cardiol 1984:53:77C-81C.
3. Kent KM, Bentivogolio LG, Block PC, et al. Percutaneous transluminal coronary angioplasty: Report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1982;49:2011-2019.
4. Leimgruber PP, Rouhin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-717.
5. Mabin TA, Holmes DR, Smith HC, et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985:71:754-760.
6. Mata LA, Bosch X, David PR, et al. Clinical and angiographic assessments 6 months after double vessel percutaneous coronary angioplasty. JACC 1985;6:1239-1244.
7. Noybuyshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty. Serial angiographic follow-up of 299 patients. JACC 1988: 12:616-623.
8. Vandormael MG, Deligonul K, Kern MJ, et al. Multilesion coronary angioplasty: Clinical and angiographic follow-up. Am J Cardiol 1987;10:246-252.
9. Chesebro JH, Webster MWI, Reeder GS, et al. Coronary angioplasty: Antiplatelet therapy reduces acute complications but not restenosis. (abstract) Circulation 1989;80(Suppl II):II-64.
10. Hartzler GO, Rutherford BD, McConahay DR, et al. High-dose steroids for prevention of recurrent restenosis post-PTCA: A randomized trial. (abstract) JACC 1987;9:185A.
11. Rose TE, Beauchamp BG, Short term high-dose steroid treatment to prevent restenosis in PTCA. (abstract) Circulation 1987;76(Suppl IV):1V-371.
12. Schwartz, L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous coronary angioplasty. N Engl J Med 1988;318:1714-1719.
13. Mehta J, Mehta P, Ostrowski N, et al. Effects of verapamil on platelet aggregation, ATP release and thromboxane generation. Thromb Res 1983;30:469-475.
14. Mehta P, Mehla J, Ostrowski N, et al. Inhibitory effect of diltiazem on platelet activation caused by calcium ionophore A 23187 plus ADP on epinephrine in subthreshold concentrations. J Lab Clin Med 1983;102:332-339.
15. Ribeiro LGT, Brandon TA, Horak JK, et al. Inhibition of platelet aggregation by verapamil: Quantification by in vivo and in vitro techniques. J Cardiovasc Pharmacol 1982;4:170-173.
16. Ross RN, Glomset JA, The pathogenesis of atherosclerosis. New Engl J Med 1976;295:369-377.
17. Ross RN: Atherosclerosis: A problem of the biology of arterial wall cells and their interaction with blood components. Arteriosclerosis 1981;1:293-311.
18. Kramsch DM, Aspen AJ, Rozier LJ. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science 1981;213:1511-1512.
19. Metcalfe JC, Moore JP, Smith GA, et al. Calcium and cell proliferation. B Med Bul 1986;42:405-412.
20. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, et al. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990;335:1109-1113.
21. Nayler WG. The molecular mechanisms involved in the anti-atherogenic effect of calcium antagonists. In: Nayler WG, ed. Second Generation of Calcium Antagonists. Berlin, Germany: Springer Verlag, 1991, pp. 139-159.
22. Sugano M, Nakashima Y, Matsushima T, et al. Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection. Arteriosclerosis 1986;6:237-241.
23. Hoberg E, Schwarz F, Schömig A, et al. Reduktion der Restenoserate nach Koronaranioplastie durch Verapumil. Resultate der Verapamil Angioplastie Studie (VAS), (abstract) Z Kardiol 1991;80:102.
24. Corcos T, David PR, Val PG, et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;1109:926-431.
25. O'Keefe JH, Giorgi LV, Hartzler GO, et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991;67:373-376.
26. Whitworth, Roubin GS, Hollman J, el al. Fffect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. JACC 1986;8:1271-1276.
27. Taylor RR, Gibbons FA, Cope DG, et al. Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol 1991;68:874-878.
28. Barath P, Arakawa K, Cao J, et al. Low dose of antitumor agents prevents smooth muscle proliferation after endothelial injury. (abstract) Am J Cardiol 1989;13:252A.
29. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle proliferation in injured arteries. Nature 1977; 256:625-626.
30. Currier AW, Pow TK, Minihan AC, et al. Colchicinc inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. (abstract) Circulation 1989:80(Suppl II):II-66.
31. Longenecker JP, Kilty LA, Johnson LI. Glucocorticoid inhibition of vascular smooth muscle cell proliferation: Influence of homologous extracellular matrix and serum mitogens. J Cell Biol 1984;98:534-541.
32. Pow TK, Currier JW, Minihan AC, et al. Low molecular heparin reduces restenosis after experimental angioplasty. Circulation 1989;80(Suppl II):II-65.
33. Prescott MF, McBride CK, Court M. Development of intimal lesion after leucocyte migration into the vascular wall. Am J Pathol 1989;135:835-846.
34. Chesebro JH, Lam JYT, Badimon L, et al. Restenosis after arterial angioplasty: A hemorrheologic response to injury. Am J Cardiol 1987;60:10B-16B.
35. Faxon DP, Sanborn TA, Haudenschild CC, et al. Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol 1984;53:72C-76C.
36. Wilentz JR, Sanborn TA, Haudenschild CC, et al. Platelet accumulation in experimental angioplasty: Time course a relation to vascular injury. Circulation 1987;75:636-642.
37. Blackshear JI, O'Callaghan WG, Califf RM. Medical approaches to prevention of restenosis after coronary angioplasty. JACC 1987;9:834-848.
38. Hollmann J, Galan K, Franco I, et al. Recurrent stenosis after coronary angioplasty. (abstract) JACC 1986,7(Suppl A):19A.
39. Margolis JR, Krieger R, Glemser E. Coronary angioplasty: Increased restenosis rate in insulin-dependent diabetics. (abstract) Circulation 1984;70(Suppl II):75.
40. Shaw RE, Myler RK, Fishman-Rosen J, et al. Clinical and morphologic factors in prediction of restenosis after multiple-vessel angioplasty. (abstract) JACC 1986;7:63A.
41. Benchimol D, Benchimol H, Bonnet J, et al. Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis. Am J Cardiol 1990;65:980-985.
42. Macdonald RG, Henderson MA, Hirshfeld JW, et al. Patient-related variables and restenosis after coronary angioplasty - a report from the M-Heart Group. Am J Cardiol 1990;66: 926-931.
43. Austin GE, Lynn M, Hollman J. Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty. Arch Pathol Lab Med 1987;111:1158-1162.
44. Chait A, Ross R, Albers J, et al. Platelet-derived growth factor stimulates low-density lipoprotein receptor activity. Proc Nat Acad Sci USA 1980;77:4084-4089.
45. Fischer-Dzoga K, Kuo YF, Wissler RW. The proliferative effect of platelets and hyperlipidemic serum on stationary primary cultures. Atherosclerosis 1983;47:35-45.
46. Johansson SR, Wiklund O, Karlsson T, et al. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty. Eur Heart J 1991;12:1020-1028.
47. Kutryk MYB, Maddaford TG, Ramijiawa B, et al. Oxidation and membrane cholesterol alters active and passive transsarcolemmal calcium movement. Circ Res 1991;68:18-26.
48. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. Cath Cardiovasc Diagn 1987;13: 1-15.
49. Reis GI, Kuntz RE, Silverman DL, et al. Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol 1991;68:1431-1435.
50. Sahni R, Maniet AR, Voci G, et al. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991;121:1600-1608.
51. Austin GE, Hollman J, Lynn MS, et al. Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis. Cleve Clin J Med 1989;56:509-514.
52. Lambert M, Bonan R, Cote G, et al. Multiple coronary angioplasty: A model to discriminate systemic and procedural factors. Am J Cardiol 1988;12:310-314.
53. Baranatha ES, Schwartz JS, Taylor L, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987;76:125-134.
54. Gruvanis M. The enigma of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiovasc Pathol 1988;2:1-5.
55. Sarembock IJ, LaVeau PJ, Sigal SL, et al. Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. Circulation 1989;80: 1029-1040.
56. Tada T, Reidy MA. Endothelial regeneration: Arterial injury followed by rapid endothelial repair induces smooth muscle-cell proliferation but not intimal thickening. Am J Pathol 1987; 129:429-433.
57. Webster MWI, Chesebro JH, Heras M, et al. Effect of balloon inflation on smooth muscle cell proliferation in porcine carotid artery. (abstract) JACC 1990;15:165A.